Anti-PD-1 antibody HX008 combined with oxaliplatin plus capecitabine for advanced gastric or esophagogastric junction cancer: a multicenter, single-arm, open-label, phase Ib trial

nork Xu, Jianming, Xu, Nong, Bai, Yuxian, Liu, Rongrui, Mao, Chenyu, Sui, Hong, Wang, Xiaofei, Jiang, Qian, Dou, Yiwei
Argitaratua izan da Oncoimmunology (2020)

HX008, an anti-PD1 antibody, plus irinotecan as second-line treatment for advanced gastric or gastroesophageal junction cancer: a multicenter, single-arm phase II trial

nork Song, Yan, Li, Ning, Li, Qun, Liang, Xinjun, Zhang, Shu, Fan, Qingxia, Yin, Xianli, Zhuang, Zhixiang, Liu, Yunpeng, Zhang, Jingdong, Kou, Xiaoge, Zhong, Haijun, Wang, Xiaofei, Dou, Yiwei, Huang, Jing
Argitaratua izan da J Immunother Cancer (2020)